SEB Asset Management AB Takes $2.49 Million Position in Healthpeak Properties, Inc. $DOC

SEB Asset Management AB bought a new stake in Healthpeak Properties, Inc. (NYSE:DOC) in the first quarter, HoldingsChannel.com reports. The fund bought 151,450 shares of the real estate investment trust’s stock, valued at approximately $2,488,000.

A number of other hedge funds also recently bought and sold shares of DOC. Swiss National Bank lifted its position in Healthpeak Properties by 9.0% during the first quarter. Swiss National Bank now owns 2,039,420 shares of the real estate investment trust’s stock valued at $33,508,000 after purchasing an additional 168,522 shares during the last quarter. Mediolanum International Funds Ltd increased its holdings in shares of Healthpeak Properties by 199.7% in the 1st quarter. Mediolanum International Funds Ltd now owns 395,624 shares of the real estate investment trust’s stock worth $6,548,000 after buying an additional 263,628 shares during the last quarter. Arjuna Capital increased its holdings in shares of Healthpeak Properties by 117.3% in the 1st quarter. Arjuna Capital now owns 33,915 shares of the real estate investment trust’s stock worth $557,000 after buying an additional 18,309 shares during the last quarter. Advisortrust Partners LLC increased its holdings in shares of Healthpeak Properties by 9.3% in the 1st quarter. Advisortrust Partners LLC now owns 26,353 shares of the real estate investment trust’s stock worth $433,000 after buying an additional 2,236 shares during the last quarter. Finally, Assetmark Inc. raised its position in shares of Healthpeak Properties by 23.0% during the 1st quarter. Assetmark Inc. now owns 532,371 shares of the real estate investment trust’s stock valued at $8,747,000 after buying an additional 99,575 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Trading Down 0.5%

Healthpeak Properties stock opened at $22.08 on Friday. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. The stock has a market cap of $15.22 billion, a PE ratio of 68.99, a price-to-earnings-growth ratio of 3.45 and a beta of 1.02. The stock has a 50-day moving average of $20.68 and a two-hundred day moving average of $18.43. Healthpeak Properties, Inc. has a one year low of $15.70 and a one year high of $22.77.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The business had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. During the same quarter in the previous year, the firm earned $0.46 earnings per share. The company’s revenue was up 7.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, research analysts anticipate that Healthpeak Properties, Inc. will post 1.75 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently announced a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be given a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 5.5%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties’s payout ratio is currently 381.25%.

Analysts Set New Price Targets

Several research firms have recently issued reports on DOC. Royal Bank Of Canada raised their price objective on Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a research note on Thursday, May 14th. Wall Street Zen raised shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Sunday, May 10th. JPMorgan Chase & Co. lifted their price objective on Healthpeak Properties from $18.00 to $21.00 and gave the company a “neutral” rating in a report on Wednesday, June 24th. Mizuho upped their price objective on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, July 6th. Finally, Wells Fargo & Company increased their target price on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 15th. Four investment analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $20.62.

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the transaction, the insider owned 7,636 shares in the company, valued at approximately $148,520.20. This represents a 59.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.23% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.